WHO Guidelines for Sickle Cell Disease Management
The World Health Organization (WHO) has introduced its first global guideline for managing sickle cell disease (SCD) during pregnancy. This initiative addresses health challenge impacting both mothers and infants. SCD is characterised by crescent-shaped red blood cells that can obstruct blood flow, leading to severe health complications. The risks associated with SCD escalate during pregnancy, increasing the likelihood of maternal mortality and obstetric complications. About Sickle Cell Disease Sickle cell disease is an inherited blood disorder. It causes red blood cells to become rigid and shaped like sickles. This abnormality can lead to blockages in blood vessels. Symptoms include severe pain, anaemia, and increased susceptibility to infections. The prevalence of SCD is particularly high in malaria-endemic regions, with sub-Saharan Africa accounting for the majority of cases. Risks During Pregnancy Pregnancy poses heightened risks for women with SCD. These women face ly incre...